Megan Wyatt

10PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 06, 2026
TLR9 Agonists Potentiate Adoptive T Cell Therapy in Cancer through a B Cell-CD2 Costimulatory Axis.

|Dec 05, 2025
T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy.

Megen C Wittling, Amalia M Rivera-Reyes, Megan M Wyatt

|Apr 14, 2025
MGAT1-Guided complex N-Glycans on CD73 regulate immune evasion in triple-negative breast cancer.

Junlong Jack Chi, Ping Xie, Mary Hongying Cheng

|Sep 18, 2024
A Paradigm Shift in Tumor Immunology: Th17 Cells and TGFβ in Intestinal Cancer Initiation.

Megan M Wyatt, Chrystal M Paulos

|Jun 20, 2024
CD8+ T cell-derived Fgl2 regulates immunity in a cell-autonomous manner via ligation of FcγRIIB.

Kelsey B Bennion, Danya Liu, Abdelhameed S Dawood

|Jan 08, 2024
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells.

Megen C Wittling, Hannah M Knochelmann, Megan M Wyatt

Pageof 2

Frequent Collaborators

8 joint publications

Chrystal M Paulos

5 joint publications

Gregory B Lesinski

4 joint publications

Guillermo O Rangel Rivera

4 joint publications

Hannah M Knochelmann